Search

Search Constraints

You searched for: Author/Creator Efebera, Yvonne A.

Search Results

1. A phase I/II study of ixazomib, pomalidomide, and dexamethasone for lenalidomide and proteasome inhibitor refractory multiple myeloma (Alliance A061202). Issue 12 (6th October 2021)

2. A Phase II trial of weekly bortezomib and dexamethasone in veterans with newly diagnosed multiple myeloma not eligible for or who deferred autologous stem cell transplantation. (8th January 2015)

3. Characterization of multiple myeloma vesicles by label‐free relative quantitation. Issue 20 (8th October 2013)

4. Daratumumab plus lenalidomide, bortezomib and dexamethasone in newly diagnosed multiple myeloma: Analysis of vascular thrombotic events in the GRIFFIN study. (16th September 2022)

5. Early versus delayed autologous stem cell transplant in patients receiving novel therapies for multiple myeloma. Issue 8 (August 2013)

6. Lower dose of antithymocyte globulin does not increase graft-versus-host disease in patients undergoing reduced-intensity conditioning allogeneic hematopoietic stem cell transplant. Issue 4 (April 2015)

8. Novel gelsolin variant as the cause of nephrotic syndrome and renal amyloidosis in a large kindred. (June 2014)

9. Tocilizumab as first-line therapy for steroid-refractory acute graft-versus-host-disease: analysis of a single-center experience. Issue 9 (29th July 2019)

10. Tocilizumab for steroid refractory acute graft-versus-host disease. Issue 1 (2nd January 2016)